Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Orstavik

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 22, 1999
[X chromosome inactivation--a biological phenomenon of clinical significance for women]K H Orstavik
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Inhibitors to factor IX contain all IgG subclasses except IgG3K H Orstavik
Lancet (London, England)|October 7, 1989
Familial occurrence of opioid-induced biliary colicK H Orstavik
Thrombosis and Haemostasis|December 23, 1981
Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasmaK H Orstavik
Lakartidningen|January 22, 2000
[X-chromosome inactivation--a biological phenomenon of clinical significance for women]K H Orstavik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 20, 1997
[Mental retardation. Progress in the search of causes means new challenge for the clinician]K H Orstavik
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Genetics of plasma concentration of von Willebrand factorK H Orstavik
British Journal of Haematology|May 1, 1981
Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulinsK H Orstavik
Thrombosis Research|May 1, 1977
Comparison of precipitating antisera against normal and abnormal factor IXK H Orstavik
Thrombosis Research|January 1, 1979
Electroimmunoassay of factor IX antigen: increased sensitivity by enzyme amplification of immunoprecipitatesK H Orstavik
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 22, 1999
[X chromosome inactivation--a biological phenomenon of clinical significance for women]K H Orstavik
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Inhibitors to factor IX contain all IgG subclasses except IgG3K H Orstavik
Lancet (London, England)|October 7, 1989
Familial occurrence of opioid-induced biliary colicK H Orstavik
Thrombosis and Haemostasis|December 23, 1981
Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasmaK H Orstavik
Lakartidningen|January 22, 2000
[X-chromosome inactivation--a biological phenomenon of clinical significance for women]K H Orstavik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 20, 1997
[Mental retardation. Progress in the search of causes means new challenge for the clinician]K H Orstavik
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Genetics of plasma concentration of von Willebrand factorK H Orstavik
British Journal of Haematology|May 1, 1981
Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulinsK H Orstavik
Thrombosis Research|May 1, 1977
Comparison of precipitating antisera against normal and abnormal factor IXK H Orstavik
Thrombosis Research|January 1, 1979
Electroimmunoassay of factor IX antigen: increased sensitivity by enzyme amplification of immunoprecipitatesK H Orstavik
Pageof 7